EV/EBITDA:
-14.64+0.61(+4.00%)Summary
- As of today, CGON EV/EBITDA is -14.64, with a rise of +0.61 (+4.00%) during the most recent trading session on December 5, 2025.
- Over the past year, CGON EV/EBITDA has increased by +3.38 (+18.76%).
- CGON EV/EBITDA is now -292.49% below its all-time high of -3.73.
Performance
CGON EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CGON EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +4.0% | -4.0% | -3.2% |
| 1M1 Month | -18.4% | +18.3% | +14.1% |
| 3M3 Months | -23.5% | +41.2% | +30.9% |
| 6M6 Months | -46.5% | +95.8% | +62.6% |
| YTDYTD | -16.4% | +82.2% | +51.0% |
| 1Y1 Year | +18.8% | +52.0% | +29.0% |
| 5Y5 Years | - | - | - |
CGON EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -12.29 | -19.1% | -15.58 | +6.0% |
| 3M | 3-Month | -11.85 | -23.5% | -15.58 | +6.0% |
| 6M | 6-Month | -7.42 | -97.3% | -15.58 | +6.0% |
| 1Y | 1-Year | -3.73 | -292.5% | -18.75 | +21.9% |
| 3Y | 3-Year | -3.73 | -292.5% | -94.71 | +84.5% |
| 5Y | 5-Year | -3.73 | -292.5% | -94.71 | +84.5% |
| All-Time | All-Time | -3.73 | -292.5% | -94.71 | +84.5% |
CGON EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -14.64(-16.4%) |
| Date | Value |
|---|---|
| 2024 | -12.58 |
FAQ
- What is CG Oncology, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for CG Oncology, Inc.?
- What is CGON EV/EBITDA year-to-date change?
- What is CG Oncology, Inc. EV/EBITDA year-on-year change?
What is CG Oncology, Inc. EV/EBITDA?
The current EV/EBITDA of CGON is -14.64
What is the all-time high EV/EBITDA for CG Oncology, Inc.?
CG Oncology, Inc. all-time high EV/EBITDA is -3.73
What is CGON EV/EBITDA year-to-date change?
CG Oncology, Inc. EV/EBITDA has changed by -2.06 (-16.38%) since the beginning of the year
What is CG Oncology, Inc. EV/EBITDA year-on-year change?
Over the past year, CGON EV/EBITDA has changed by +3.38 (+18.76%)